Syndax Pharmaceuticals SNDX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's interest income?
- Syndax Pharmaceuticals (SNDX) reported interest income of $3.56M in Q1 2026.
- How has Syndax Pharmaceuticals's interest income changed year-over-year?
- Syndax Pharmaceuticals's interest income decreased by 50.4% year-over-year, from $7.18M to $3.56M.
- What is the long-term trend for Syndax Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's interest income has grown at a 174.2% compound annual growth rate (CAGR), from $402K to $22.73M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.